Dimitrios P. Kontoyiannis, MD, MS, ScD, PhD

The University of Texas MD Anderson Cancer Center

Poster(s):

• (827) Adjunct terbinafine in patients with leukemia and invasive fusariosis with skin lesions: Discordance between responses of skin lesions and systemic outcomes
  Thursday, October 12, 2023

  12:15 PM – 1:30 PM US ET

• (828) Do lung co-infections influence outcome in patients with hematological malignancies and culture-documented invasive pulmonary aspergillosis?
  Thursday, October 12, 2023

  12:15 PM – 1:30 PM US ET

• (848) Discordant Chest Radiography and Computed Tomography Findings in Patients with Hematologic Malignancy and Invasive Mucormycosis: What Are the Prognostic Implications?
  Thursday, October 12, 2023

  12:15 PM – 1:30 PM US ET

• (849) Histopathology of Cutaneous Invasive Fungal Infections in a Tertiary Cancer Center: Causes, Discordance with Culture, and Histopathologic Determinants of Outcome
  Thursday, October 12, 2023

  12:15 PM – 1:30 PM US ET

• (2589) Legionella pneumonia in cancer patients: 12-year experience at MD Anderson Cancer Center 2009-2021
  Saturday, October 14, 2023

  12:15 PM – 1:30 PM US ET